锦波生物
(920982)
| 流通市值：95.91亿 | | | 总市值：201.01亿 |
| 流通股本：5490.51万 | | | 总股本：1.15亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 375,372,555.96 | 1,595,372,919.28 | 1,295,732,666.6 | 858,703,187.63 |
| 营业收入 | 375,372,555.96 | 1,595,372,919.28 | 1,295,732,666.6 | 858,703,187.63 |
| 二、营业总成本 | 218,368,822.25 | 825,957,509.81 | 620,389,060.82 | 392,263,236 |
| 营业成本 | 56,981,893.11 | 172,119,657.78 | 119,180,681.79 | 80,059,525.05 |
| 税金及附加 | 6,655,245.34 | 27,271,605.1 | 21,376,768.42 | 12,742,937.39 |
| 销售费用 | 87,892,692.94 | 375,946,448.97 | 289,442,165.63 | 180,787,544.42 |
| 管理费用 | 41,347,360.26 | 136,520,971.34 | 112,971,706.25 | 68,496,261.12 |
| 研发费用 | 22,470,678.12 | 106,011,667.35 | 71,261,580.37 | 45,796,192.02 |
| 财务费用 | 3,020,952.48 | 8,087,159.27 | 6,156,158.36 | 4,380,776 |
| 其中:利息费用 | 2,428,335.95 | 7,375,624.82 | 5,680,008.72 | 3,996,344.32 |
| 其中:利息收入 | 203,061.63 | 855,599.4 | 622,359.06 | 393,048.81 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 2,052,393.98 | 6,176,174.86 | 4,889,164.88 | 2,885,501.07 |
| 资产减值损失(新) | -364,911.98 | -23,085,134.39 | -11,561,283.52 | -10,822,324.14 |
| 信用减值损失(新) | -1,158,924.4 | -8,027,981.08 | -7,805,119.56 | -3,693,179.11 |
| 其他收益 | 9,534,547.26 | 23,808,685.36 | 10,182,080.7 | 7,605,759.58 |
| 四、营业利润 | 167,066,838.57 | 768,287,154.22 | 671,048,448.28 | 462,415,709.03 |
| 加:营业外收入 | 36,551.13 | 639,821.45 | 111,490.62 | 33,304.61 |
| 减:营业外支出 | 138,703.18 | 8,566,680.85 | 4,463,477.39 | 4,194,620.02 |
| 五、利润总额 | 166,964,686.52 | 760,360,294.82 | 666,696,461.51 | 458,254,393.62 |
| 减:所得税费用 | 26,005,600.83 | 114,649,788.24 | 102,056,444.36 | 67,543,224.26 |
| 六、净利润 | 140,959,085.69 | 645,710,506.58 | 564,640,017.15 | 390,711,169.36 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 140,959,085.69 | 645,710,506.58 | 564,640,017.15 | 390,711,169.36 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 140,454,965.87 | 652,128,968.1 | 568,273,346.52 | 392,057,939.84 |
| 少数股东损益 | 504,119.82 | -6,418,461.52 | -3,633,329.37 | -1,346,770.48 |
| 扣除非经常损益后的净利润 | 131,092,491.15 | 635,506,016.42 | 559,736,614.17 | 387,262,463.17 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.22 | 5.67 | 4.94 | 3.41 |
| (二)稀释每股收益 | 1.22 | 5.67 | 4.94 | 3.41 |
| 九、综合收益总额 | 140,959,085.69 | 645,710,506.58 | 564,640,017.15 | 390,711,169.36 |
| 归属于母公司股东的综合收益总额 | 140,454,965.87 | 652,128,968.1 | 568,273,346.52 | 392,057,939.84 |
| 归属于少数股东的综合收益总额 | 504,119.82 | -6,418,461.52 | -3,633,329.37 | -1,346,770.48 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-29 | 2025-08-11 |
| 审计意见(境内) | | 标准无保留意见 | | |